Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Buy
107,324
+2,903
+3% +$526K 0.17% 71
2026
Q1
$15.4M Buy
104,421
+212
+0.2% +$34.5K 0.17% 66
2025
Q4
$20.3M Sell
104,209
-4,798
-4% -$1.14M 0.26% 48
2025
Q3
$30.7M Sell
109,007
-5,944
-5% -$1.51M 0.65% 26
2025
Q2
$25.1M Sell
114,951
-13,467
-10% -$2.17M 0.59% 31
2025
Q1
$18M Buy
128,418
+10,016
+8% +$1.63M 0.48% 40
2024
Q4
$19.8M Buy
118,402
+4,003
+3% +$711K 0.51% 35
2024
Q3
$19.5M Buy
114,399
+13,525
+13% +$1.96M 0.53% 37
2024
Q2
$14.2M Sell
100,874
-561
-0.6% -$69.7K 0.42% 42
2024
Q1
$12.7M Buy
+101,435
New +$11.6M 0.4% 52

Other funds holding ORCL

Allianz's ORCL Position: Q2 2026 in Review

Allianz increased its Oracle (ORCL) stake by 2.8% in Q2 2026, buying an estimated $526K and bringing the position to 107,324 shares worth $15.7M. The position accounts for 0.17% of the portfolio, ranked #71.

Allianz first reported a position in ORCL in Q1 2024 and has held it in 10 quarters since. The position peaked at $30.7M in Q3 2025. 3,513 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Allianz held 107,324 shares of Oracle worth $15.7M as of Q2 2026.
  • Allianz bought 2,903 Oracle shares in Q2 2026, an estimated $526K.
  • Oracle made up 0.17% of Allianz's portfolio in Q2 2026, its #71 holding.
  • Allianz first reported a position in Oracle in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Oracle position peaked at $30.7M in Q3 2025.
  • 3,513 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.